Results 181 to 190 of about 2,063 (198)

Expanded analysis of Lyso-GB3 analogues and correlation with total Lyso-GB3 and Fabry status in 59 clinical patients

Molecular Genetics and Metabolism, 2018
Brian Netzel, Dimitar Gavrilov, Dietrich Matern, Devin Oglesbee, Kimiyo Raymond, Piero Rinaldo, Silvia Tortorelli, Matthew Schultz   +7 more
openaire   +1 more source

Transcriptomics characterization of lyso-Gb3 impact on cultured wild-type human podocytes

Molecular Genetics and Metabolism, 2020
Maria Dolores Sanchez-Niño, Alberto Ortiz   +1 more
openaire   +1 more source

Plasma lyso-Gb3 as a diagnostic marker for Fabry disease

Molecular Genetics and Metabolism, 2018
Sarah Young, Haoyue Zhang, Jian Dai, Patricia McCaw, James Beasley, Denise Peterson, Ashlee Stiles, Marie McDonald, Dwight Koeberl, Deeksha Bali   +9 more
openaire   +1 more source

Lyso-Gb3: A valid follow-up marker of treatment in male Fabry disease patients?

Molecular Genetics and Metabolism, 2020
Susanne Walls, Miia Rainto, Ilkka Kantola   +2 more
openaire   +1 more source

Relative quantification of seven urinary Lyso-Gb3 analogues as Fabry disease biomarkers

Molecular Genetics and Metabolism, 2013
Pamela Lavoie, Michel Boutin, Christiane Auray-Blais   +2 more
openaire   +1 more source

What about the excretion of lyso-Gb3 in Fabry adults compared to children?

Molecular Genetics and Metabolism, 2014
Christiane Auray-Blais, Catherine-Marie Blais, Michel Boutin, Pamela Lavoie   +3 more
openaire   +1 more source

8. How useful is urinary lyso-Gb3 as a biomarker for Fabry disease?

Molecular Genetics and Metabolism, 2010
Christiane Auray-Blais, René Gagnon, David G. Warnock, Sarah P. Young, David S. Millington, Joe T.R. Clarke   +5 more
openaire   +1 more source

Agreement of dried blood spot lyso-Gb3 concentrations obtained from different laboratories in patients with Fabry disease

Clinical Chemistry and Laboratory Medicine (CCLM), 2020
Constantin Gatterer, Martina Gaggl, Gerald Mundigler, Paulus Rommer, Senta Graf, Gere Sunder-Plassmann   +5 more
openaire   +2 more sources

Globotriaosylsphingosine (Lyso-GB3 bzw. Lyso-GL3), an Excellent Biomarker for Children with Fabry Disease

Neuropediatrics, 2017
N. Karabul, T. Marquardt, M. Petersen, A. Beckmann, E. Namal, T. Lücke   +5 more
openaire   +1 more source

Lyso-Gb3 is as a primary biomarker for Fabry disease screening among high-risk contingents

Molecular Genetics and Metabolism, 2019
Kirill Savostyanov, Alexander Pushkov, Natalya Mazanova, Lolita Pak, Lyudmila Kuzenkova, Tatyana Podkletnova, Alexander Pakhomov, Alexey Sukhozhenko, Sergey Moiseev   +8 more
openaire   +1 more source